Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
  • Jack Rivkin, On Long- Short Mutual Funds
    yeah, if only ARLSX had not done and were not doing quite inferiorly, 3y/1y/ytd, compared with, you know, GLRBX, FPACX, JABAX, and ICMBX, to use my own favorite lower-risk balanced funds. I wonder what's been happening.
  • MFLDX and AUM
    You could always move the money into a smaller, nimbler MFO L/S favorite like ARLSX. That fund only has a little over $200m in assets... Except that fund is down over 4% for the year. (yes, I'm being facetious).
    Not to minimize your concerns because the asset growth of MFLDX is staggering, and on the surface doesn't appear to be customer friendly. But the risk adjusted return for this fund is terrific. There are other consistently well managed funds with high AUM's that do just fine. A good example is my favorite, FPACX. These funds are never the high fliers at any short term interval but are measured for good returns over time.
    You have to be comfortable with what you own, but yeah, I do think you are jumping the gun. Of course, this is coming from someone that doesn't own it.
  • What were your "UP" funds today on a largely "down" day?
    Another down day today 3/13/2014:
    Markets:
    Dow -1.41%
    Nasdaq -1.46%
    S&P -1.19%
    Russell 2000 -1.23%
    EFA -1.86%
    EEM -1.80%
    GLD +0.34%
    GDX +2.64%
    AGG +0.26%
    Alternative Funds:
    TFS Market Neutral TFSMX -0.34%
    TFS Hedged Futures TFSHX 0.00%
    Whitebox Market Neutral Equity Investor WBLSX -0.36%
    Whitebox Tactical Opportunities Investor WBMAX 0.00%
    ASTON/River Road Long-Short N ARLSX -0.78%
    BlackRock Global Long/Short Equity Inv A BDMAX +0.09%
    LS Opportunity LSOFX -0.85%
    PIMCO EqS Long/Short D PMHDX -0.65%
    MainStay Marketfield I MFLDX -0.92%
    Robeco Boston Partners L/S Equity Inv BPLEX +0.43%
    Robeco Boston Partners L/S Rsrch Inv BPRRX -0.42%
    RiverPark Structural Alpha Retail RSAFX -0.29%
    RiverPark Long/Short Opportunity Retail RLSFX -1.36%
    RiverPark/Gargoyle Hedged Value Retail RGHVX -0.74%
    AQR Multi-Strategy Alternative N ASANX +0.52%
    AQR Diversified Arbitrage N ADANX +0.09%
    AQR Risk Parity N AQRNX +0.09%
  • I purchased ARLSX and so far not so good
    Several of ARLSX's shorts are up a lot short term, too - UNG, EA, and ESG about 20%, and UAL just shy of that. From a quick look at the full holdings (via M* premium), appears many of their shorts are up ... though again this is short term.
  • I purchased ARLSX and so far not so good
    Yup its ARLSX sorry.. But I did like the video although I wasn't rude like the boy .I did think based on the number of hits that the punishment did not fit the crime
  • I purchased ARLSX and so far not so good
    ARLSX? The fund is probably facing some difficulty from its largest holding (6% of the fund) -22% YTD.
  • I purchased ARLSX and so far not so good
    The purchase of ARLSX was on Jan 23 (not perfect timing ) but it didn't seem to protect me on the downside or participate on the upside. The loss is not big (-2%) but my readings about this asset class on this site suggested this type of investment usually does not work but it does for this fund. Did I misunderstand?
    I am certainly not planning to sell soon but am having second thoughts.
    Spelling of Fund symbol corrected(what was the position down 6% as noted by Scott
  • RiverPark Gargoyle Hedged Value conference call highlights
    Well, this new semiretiree just bought more, based on the call, and it is now a high percentage, with ARLSX, of my bucket 2, meaning needed few years out, like 2-3-4. Perhaps imprudent on my part. ARLSX has not been doing well lately (explans welcome), and this bucket also has some of the better balanced funds in it. Benz and ilk would say all of this should be cash or cashlike.
    Don't know what to make 08 myself although reduced slump there is among the chief criteria for all of my all-equity bucket 3, fwiw.
  • Professor David Snowball featured in Bottom Line Personal
    Bottom Line publishes a number of micro-articles each issue, say 150 - 500 words. This was one of those.
    At base, Mark called me and said their readers were fretting about volatility and he asked my thoughts on minimum-vol or low-vol ETFs. I am, eternally, skeptical in part because traditionally low-vol sectors are bid up and undergoing structural changes (utilities, for example).
    I suggested that there were three basic volatility management strategies: absolute value investing with a concurrent emphasis on cash, long-short investing, and long hedged with an options overlay.
    They asked for three examples in each category (BRTNX, ARLSX, RGHVX ... )but they like larger funds with longer records, and they were a bit hesitant on hedging strategies so ...
    David
  • LSOFX LS Opportunity Fund 2013 Year-end Report
    Reply to @STB65: An intriguing graph/dataset and an intriguing question.
    The Gold standard in long/short investing is BPLEX and they've long claimed that their niche (small cap long/short - they are all cap but few other l/s funds venture into these smaller market caps) is distinctive and profitable.
    Three notes:
    LSOFX, at $90 million, is a much better than the average l/s fund with 12% in micro- and small cap stocks. The average l/s fund has about 10% in micro- to small. The largest distinction is in micro: 3.8% for LSOFX, 1.3% for the group. Last summer, LS Advisors reported a strategy capacity of $2 billion with a soft-close at $1 billion to preserve flexibility.
    BPLEX, at $810 million but closed at a much smaller size, is much better than LSOFX and much, much better than the average l/s fund (total return since LSOFX's inception is 30.6% for LS, 42% for BPLEX in the same period, 15% for the herd). It holds 33% micro- to small cap (against the group average 10%) and 21% in micro (against barely 1%).
    ARLSX, at $220 million, has since inception outperformed both with no micro-cap exposure and slightly below-average small cap exposure. They believe that their strategy capacity is well over a billion - perhaps $1.5, perhaps $2 depending on market conditions.
    The decision to close BPLEX at around $500 million seems to validate two conclusions: they are unique opportunities (poor analyst coverage, inefficient pricing) in the small cap arena and you need to be small to benefit from them.
    For what that's worth,
    David
  • What were your "UP" funds today on a largely "down" day?
    Today: Mon. 2/3/2014
    Markets:
    Dow -2.08%
    S&P 500 -2.28%
    Nasdaq -2.61%
    Russell 2000 -3.21%
    10 yr. bond -3.26%
    Gold -0.28%
    EFA -2.04%
    EEM -2.83
    VIX +16.46%
    Alternative ETFs/Mutual Funds:
    Global X Guru Index ETF GURU -2.92%
    Barclays S&P 500 Dynamic VEQTOR ETN VQT +0.01%
    TFS Market Neutral TFSMX -0.40
    Whitebox Long Short Equity Investor WBLSX -0.09%
    Whitebox Tactical Opportunities Investor WBMAX +0.32%
    ASTON/River Road Long-Short N ARLSX -0.70%
    BlackRock Global Long/Short Equity Inv A BDMAX -0.25%
    LS Opportunity LSOFX -1.34%
    PIMCO EqS® Long/Short D PMHDX -1.27%
    MainStay Marketfield I MFLDX -1.47%
    Robeco Boston Partners L/S Equity Inv BPLEX +0.48%
    Robeco Boston Partners L/S Rsrch Inv BPRRX -1.00%
    RiverPark Long/Short Opportunity Retail RLSFX -1.29%
    RiverPark/Gargoyle Hedged Value Retail RGHVX -1.94%
    AQR Multi-Strategy Alternative N ASANX -0.73%
    AQR Diversified Arbitrage N ADANX 0.00%
    AQR Risk Parity N AQRNX -0.07 -0.66%
    BPLEX and both Whitebox funds did quite well on this very "down" day.
    Any other funds that performed well today?
  • our February 2014 issue is up
    Thought you might be interested. Both Edward Studzinski and Charles have cool and thoughtful essays. We bumped up the number of fund profiles to four. It would have been higher except for a couple non-responsive fund firms (I hate writing before I know the facts). I mumbled a bit about writing a book, shared the ARLSX call highlights and a few words from the managers of RiverPark Gargoyle Hedged Value, who'll be joining us on the February call.
    As ever,
    David
  • Best Performing Funds On A Down Day (Friday)
    Fund 1/24/14 2013 2008
    Greenspring GRSPX -1.24% +18% -12%
    Janus Balanced JANBX -1.14% +20% -15%
    Fpa Crescent FPACX -0.98% +22% -21%
    Whitebox WBMAX +0.24% +16% NA
    Marketfield MFADX -1.40% +17% -13%
    Yacktman Focus YAFFX -1.09% +27% -23%
    ASTON Long-Short N ARLSX -0.93% +18% NA
    Robeco L/S Rsrch Inv BPRRX -1.08% +17% NA
    Good Harbor GHUAX -3.28%?? +21% NA
    So boring stocks win -why shouldn't FPACX be major part of long term portfolio??
    Add in YAFFX, GRSPX, JANBX and throw in a few international from Grandeur Peak, Matthews and you are done.
  • Still A Textbook Start To 2014
    Quick look at some board favorites with M* YTD performance plot:
    image
    RNSIX back in lead.
    Then ARIVX.
    Next PIMIX and BOND.
    WBMIX.
    SPY.
    ARLSX slowest out of the gate.
  • Aston River Road conference call highlights
    Dear friends,
    We spoke with Daniel Johnson and Matt Moran, managers for the River Road Long-Short Equity strategy which is incorporated in Aston River Road Long-Short (ARLSX). Mike Mayhew, one of the Partners at Aston Asset, was also in on the call to answer questions about the fund's mechanics. About 60 people joined in.
    The highlights, for me, were:
    the fund's strategy is sensible and straightforward, which means there aren't a lot of moving parts and there's not a lot of conceptual complexity. The fund's stock market exposure can run from 10 - 90% long, with an average in the 50-70% range. The guys measure their portfolio's discount to fair value; if their favorite stocks sell at a less than 80% of fair value, they increase exposure. The long portfolio is compact (15-30), driven by an absolute value discipline, and emphasizes high quality firms that they can hold for the long term. The short portfolio (20-40 names) is stocked with poorly managed firms with a combination of a bad business model and a dying industry whose stock is overpriced and does not show positive price momentum. That is, they "get out of the way of moving trains" and won't short stocks that show positive price movements.
    the fund grew from $8M to $207M in a year, with a strategy capacity in the $1B - 1.5B range. They anticipate substantial additional growth, which should lower expenses a little (and might improve tax efficiency - my note, not theirs). Because they started the year with such a small asset base, the expense numbers are exaggerated; expenses might have been 5% of assets back when they were tiny, but that's no longer the case.
    the vogue for dividend-paying stocks drove valuations sharply higher and so some of the stocks they short pay high diviends; that increases the fund's expenses because they've got to repay those dividends but the managers believe that the shorts will turn out to be profitable even so.
    the guys have no client other than the fund, don't expect ever to have one, hope to manage the fund until they retire and they have 100% of their liquid net worth in it.
    their target is "sleep-at-night equity exposure," which translates to a maximum drawdown (their worst-case market event) of no more than 10-15%. They've been particularly appalled by long/short funds that suffered drawdowns in the 20-25% range which is, they say, not consistent with why folks buy such funds.
    they've got the highest Sharpe ratio of any L/S fund, their longs beat the market by 900 bps, their shorts beat the inverse of the market by 1100 bps and they've kept volatility to about 40% of the market's while capturing 70% of its total returns.
    A lot of the Q&A focused on the fund's short portfolio and a little on the current state of the market. The guys note that they tend to generate ideas (they keep a watchlist of no more than 40 names) by paging through Value Line. They focus on fundamentals (let's call it "reality") rather than just valuation numbers in assembling their portfolio. They point out that sometimes fundamentally rotten firms manage to make their numbers (e.g., dividend yield or cash flow) look good but, at the same time, the reality is that it's a poorly managed firm in a failing industry. On the flip side, sometimes firms in special situations (spinoffs or those emerging from bankruptcy) will have little analyst coverage and odd numbers but still be fundamentally great bargains. The fact that they need to find two or three new ideas, rather than thirty or sixty, allows them to look more carefully and think more broadly. That turns out to be profitable.
    If other folks have stuff to add, I'd be grateful for their commentary. An mp3 of the call is available on Chorus Call's servers now, and it will migrate to the Observer's by month's end.
    David
    Two apologies. In the middle of my introductory comments, there was some freakish noise that sounded like an electric pencil sharpener. I'm guessing it was the HVAC system switching to night-time mode but I don't really know. And I had a typo in the reminder: we mentioned 7-8 Eastern about six times then slipped and called it 7-8 Central once. (Nuts.) Apologies to anyone excluded by the goof.
  • ARLSX conference call has been moved to Wednesday, January 15th
    There is an interesting info in their prospectus: The fee for ARLSX is 5.08%, which become 3.16% after fee waiver, with fine print: For a period of up to three years from the fiscal year end during which such amount was waived or reimbursed (1.92%), the adviser is entitled to be reimbursed by the Fund for fees waived...
    Expenses 1.70% reported by Morningstar do not include Dividend and Interest Expense on Short Sales 1.41%, and do not mention the fee waiver of 1.92% and its subsequent reimbursement.
  • ARLSX conference call has been moved to Wednesday, January 15th

    Here's an update that I just mailed to the 60 or so registrants for the call: the good folks at Aston Asset Management, adviser to the fund, discovered yesterday that a January 14th call would run afoul FINRA regulations. There's an embargo on the release of certain sorts of portfolio information for the 15 days following the end of a calendar quarter. A call on the 14th could occur only if Matt and Dan said nothing about portfolio positioning after 9/30 but a call after the close of the markets on the 15th was in the clear. At the risk of losing some of the folks already committed to a Tuesday call, we shifted it to Wednesday.
    All of the original registration information remains valid: the link (below) still works, the registration and assigned PINs remain the same. It's just 24 hours later.
    For what interest that holds,
    David
    --------------------
    Just a reminder of next week's conference call with the managers of ASTON River Road Long Short. The copy below is a lightly-edited version of what I mailed out to the folks on our masterlist this afternoon.
    I’d like to invite you to join a conversation with Matt Moran, manager of ASTON River Road Long Short Fund (ARLSX). Last winter we spent time talking with the managers of really promising hedged funds, including a couple who joined us on conference calls. ARLSX best matched my own predilections and I subsequently invested a bit in the fund. That does not say that we believe this is “the best” long/short fund (an entirely pointless designation), just that it’s the fund that best matched my own concerns and interests. The fund returned 18% in 2013, placing it in the top third of all long/short funds.
    I was struck primarily by the extensiveness and thoughtfulness of Matt’s risk management system, though the promise that the fund might outperform the stock market by 200 bps/year over a full, 3-5 year market cycle was attractive as well.
    Matt and co-manager Dan Johnson have agreed to join us for a second conversation. Matt has been kicking around ideas for what he’d like to talk about. His short-list includes:

    • How we think about our performance in 2013 and, in particular, why we’re satisfied with it given our three mandates (equity-like returns, reduced volatility, capital preservation)
    • Where we are finding value on the long side. (It’s a struggle.)
    • How we’re surviving on the short side. (It’s a huge challenge.) Really, how many marginal businesses can keep hanging on because of the Fed’s historic generosity? Stocks must ultimately earn what underlying business earns and a slug of these firms are earning …
    • But, too, we have a strong desire not to be carried out in body bags on short side.
    Our conference call with Matt and Dan will beWednesday, January 15, from 7:00 - 8:00 p.m. EST. Just click REGISTER and you'll take been to the Chorus Call website where you'll register and receive a toll-free number and a PIN. As before, we'll try to divide the call in thirds: in the first third, they will talk us through the fund's genesis, universe and strategy. In the middle third, I'll ask a handful of questions - some suggested by folks on the Observer's discussion board. For the final third, we'll open the lines to your questions. As always it's a simple dial-in; there's no web component to it.
    If you can't make it but have questions for the guys, please share them and I'll raise as many as I can in the time available (when possible I cheat on the side of giving more time to listeners' questions than my own, but I do usually work in three or four).
    As ever,
    David
  • Better than Marketfield?
    It looks like a good performing long-short fund. Performance was marginally better than ARLSX and BPRRX (which I believe contain mostly US stocks), but by eyeballing it, BDMIX may have done it with less volatility. PMHIX and LSOFX performed better, but with what looks like greater volatility (can't say for sure but my guess is both may be more long biased, and PMHIX may have a more concentrated portfolio). I'm looking forward to see how the new Robeco global long-short fund performs.
  • RGHVX
    For what interest it holds, I've scheduled a conference call with the managers of RGHVX for February. (Also with Matt Moran of ARLSX in January.) I'll post details in tomorrow's issue.
    As ever,
    David